Pharmacokinetics and Optimal Timing of Dronedarone Initiation Following Long-term Amiodarone in Patients With Paroxysmal or Persistent Atrial Fibrillation
NCT01199081
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
154
Enrollment
INDUSTRY
Sponsor class
Conditions
Atrial Fibrillation
Interventions
DRUG:
Dronedarone
Sponsor
Sanofi